291 related articles for article (PubMed ID: 28881141)
41. Designing S100A9-Targeted Plant Virus Nanoparticles to Target Deep Vein Thrombosis.
Park J; Wen AM; Gao H; Shin MD; Simon DI; Wang Y; Steinmetz NF
Biomacromolecules; 2021 Jun; 22(6):2582-2594. PubMed ID: 34060817
[TBL] [Abstract][Full Text] [Related]
42. Preparation, characterization and in vitro thrombolytic activity of a novel streptokinase foam.
Farret AN; Azevedo EP; Raffin FN
J Thromb Thrombolysis; 2014; 38(2):176-82. PubMed ID: 24590503
[TBL] [Abstract][Full Text] [Related]
43. Recanalization therapies for acute ischemic stroke.
Broderick JP
Semin Neurol; 1998; 18(4):471-84. PubMed ID: 9932618
[TBL] [Abstract][Full Text] [Related]
44. The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi.
Kotb E
Biotechnol Prog; 2014; 30(3):656-72. PubMed ID: 24799449
[TBL] [Abstract][Full Text] [Related]
45. P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1.
Dong N; Da Cunha V; Citkowicz A; Wu F; Vincelette J; Larsen B; Wang YX; Ruan C; Dole WP; Morser J; Wu Q; Pan J
Thromb Haemost; 2004 Nov; 92(5):956-65. PubMed ID: 15543321
[TBL] [Abstract][Full Text] [Related]
46. Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery.
Ren T; Mi Y; Wei J; Han X; Zhang X; Zhu Q; Yue T; Gao W; Niu X; Han C; Wei B
Molecules; 2024 May; 29(10):. PubMed ID: 38792186
[TBL] [Abstract][Full Text] [Related]
47. Thrombolytic Agents: Nanocarriers in Targeted Release.
Shen M; Wang Y; Hu F; Lv L; Chen K; Xing G
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833868
[TBL] [Abstract][Full Text] [Related]
48. Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo.
Jin HJ; Zhang H; Sun ML; Zhang BG; Zhang JW
J Thromb Thrombolysis; 2013 Nov; 36(4):458-68. PubMed ID: 23728739
[TBL] [Abstract][Full Text] [Related]
49. Cryo-electron tomography investigation of serum albumin-camouflaged tobacco mosaic virus nanoparticles.
Gulati NM; Pitek AS; Steinmetz NF; Stewart PL
Nanoscale; 2017 Mar; 9(10):3408-3415. PubMed ID: 28112764
[TBL] [Abstract][Full Text] [Related]
50. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
Bell WR
Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
[TBL] [Abstract][Full Text] [Related]
51. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
[TBL] [Abstract][Full Text] [Related]
52. Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases.
Tadayon A; Jamshidi R; Esmaeili A
Int J Pharm; 2015 Nov; 495(1):428-438. PubMed ID: 26363110
[TBL] [Abstract][Full Text] [Related]
53. Recent strategies on targeted delivery of thrombolytics.
Huang T; Li N; Gao J
Asian J Pharm Sci; 2019 May; 14(3):233-247. PubMed ID: 32104455
[TBL] [Abstract][Full Text] [Related]
54. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
Samaniego EA; Linfante I; Dabus G
Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
[TBL] [Abstract][Full Text] [Related]
55. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
56. Nanomedicine progress in thrombolytic therapy.
Zenych A; Fournier L; Chauvierre C
Biomaterials; 2020 Nov; 258():120297. PubMed ID: 32818824
[TBL] [Abstract][Full Text] [Related]
57. Zebrafish model of photochemical thrombosis for translational research and thrombolytic screening in vivo.
Lee IJ; Yang YC; Hsu JW; Chang WT; Chuang YJ; Liau I
J Biophotonics; 2017 Apr; 10(4):494-502. PubMed ID: 27174426
[TBL] [Abstract][Full Text] [Related]
58. A new application of plant virus nanoparticles as drug delivery in breast cancer.
Esfandiari N; Arzanani MK; Soleimani M; Kohi-Habibi M; Svendsen WE
Tumour Biol; 2016 Jan; 37(1):1229-36. PubMed ID: 26286831
[TBL] [Abstract][Full Text] [Related]
59. Could advanced drug delivery systems be the future in cardiovascular revascularization medicine?
Zuin M; Rigatelli G; Faggian G; L'Erario R; Chinaglia M; Roncon L
Vascular; 2017 Aug; 25(4):447-448. PubMed ID: 27928063
[TBL] [Abstract][Full Text] [Related]
60. Recombinant peptides in thrombolysis.
Campbell J; Hilleman D
Semin Thromb Hemost; 2010 Jul; 36(5):529-36. PubMed ID: 20632250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
